AstraZeneca reported $3.6B in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alcon AG ALC:SW USD 483M 96M
Amgen AMGN:US USD 3.5B 62M
AstraZeneca AZN:LN USD 3.6B 404M
Astrazeneca AZN:US USD 3.6B 404M
AstraZeneca AZN:SS USD 3.6B 404M
Bayer BAYN:GR EUR 2.45B 2.31B
Biogen BIIB:US USD 992.8M 82.9M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Eli Lilly And LLY:US USD 2.31B 308.9M
Fresenius FRE:GR EUR 1.62B 142M
Fresenius Medical Care FME:GR EUR 771M 27M
Galapagos GLPG:NA EUR -31698000 12.18M
Gilead Sciences GILD:US USD 3.28B 731M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Hikma Pharmaceutical HIK:LN USD 349M 19M
Lonza Group LONN:SW CHF 987M 198M
Merck MRK:GR EUR 1.81B 14M
Novartis NOVN:VX USD 4.69B 34M
Orion ORNBV:FH EUR 257.4M 174.3M
Pfizer PFE:US USD 10.52B 2.78B
Philips PHIA:NA EUR 630M 154M
Recordati REC:IM EUR 162.47M 7.47M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M